PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32079672-4 2020 We searched PubMed for studies on genetically confirmed monogenic dystonia treated with GPi DBS documenting pre-surgical and post-surgical assessments using the Burke-Fahn-Marsden Dystonia Rating Scale Motor Score (BFMMS) and Burke-Fahn-Marsden Disability Score (BFMDS). dibromsalan 92-95 glucose-6-phosphate isomerase Homo sapiens 88-91 32079672-10 2020 CONCLUSIONS: GPi DBS outcomes vary across monogenic dystonias. dibromsalan 17-20 glucose-6-phosphate isomerase Homo sapiens 13-16 30123518-9 2018 Dystonia did not improve significantly with botulinum toxin, levodopa or trihexyphenidyl, but has shown marked improvement since DBS implantation in the GPi. dibromsalan 129-132 glucose-6-phosphate isomerase Homo sapiens 153-156 31349224-1 2019 Stimulating cholinergic neurons causes urinary incontinence after DBS of the Gpi. dibromsalan 66-69 glucose-6-phosphate isomerase Homo sapiens 77-80 31275687-0 2019 Psychiatric and Behavioral Complications of GPi DBS in an Adolescent with Myoclonus Dystonia. dibromsalan 48-51 glucose-6-phosphate isomerase Homo sapiens 44-47 31922299-4 2020 METHODS: Two groups of patients with focal or segmental dystonia were included in the study: 6 patients with GPi-DBS and 8 without DBS (control group). dibromsalan 113-116 glucose-6-phosphate isomerase Homo sapiens 109-112 31922299-7 2020 RESULTS: In patients with GPi-DBS (stimulation ON and OFF), activity at rest was reduced in a prefrontal network, and during the motor task, sensorimotor cortex activity was lower than in patients without DBS. dibromsalan 30-33 glucose-6-phosphate isomerase Homo sapiens 26-29 31922299-8 2020 Within-group contrasts (tapping > rest) showed less extensive task-induced motor network activation in GPi-DBS patients than in non-DBS controls. dibromsalan 107-110 glucose-6-phosphate isomerase Homo sapiens 103-106 30464181-1 2018 Clinical benefits of pallidal deep brain stimulation (GPi DBS) in dystonia increase relatively slowly suggesting slow plastic processes in the motor network. dibromsalan 58-61 glucose-6-phosphate isomerase Homo sapiens 54-57 30464181-4 2018 The acute effects of GPi DBS were associated with a shortening of the motor response whereas the grey matter of chronically treated patients with a better clinical outcome showed hypertrophy of the supplementary motor area and cerebellar vermis. dibromsalan 25-28 glucose-6-phosphate isomerase Homo sapiens 21-24 30464181-6 2018 Importantly, good responders to GPi DBS showed a similar level of short-latency intracortical inhibition in the motor cortex as healthy controls whereas non-responders were unable to increase it. dibromsalan 36-39 glucose-6-phosphate isomerase Homo sapiens 32-35 27441097-4 2016 CASE REPORT: A 24-year-old male underwent left Gpi DBS for medically refractory HT. dibromsalan 51-54 glucose-6-phosphate isomerase Homo sapiens 47-50 29137852-11 2018 Understanding causes of GPi-DBS-induced speech changes can improve DBS programming. dibromsalan 28-31 glucose-6-phosphate isomerase Homo sapiens 24-27 29246604-9 2017 RESULTS: Bilateral GPi DBS improved the BFMDRS total movement score by 65% at short-term follow-up and by 53% at long-term follow-up when compared to baseline scores. dibromsalan 23-26 glucose-6-phosphate isomerase Homo sapiens 19-22 29246604-13 2017 CONCLUSION: Our results showed that bilateral GPi DBS in craniocervical dystonia is effective and safe. dibromsalan 50-53 glucose-6-phosphate isomerase Homo sapiens 46-49 28590521-8 2017 The GPi reemerged in the late 1990s as a major stereotactic target for DBS in dystonia and, recently, in Tourette syndrome. dibromsalan 71-74 glucose-6-phosphate isomerase Homo sapiens 4-7 28590521-9 2017 Lately, lesioning of the GPI is being proposed to treat refractory status dystonicus or to treat DBS withdrawal syndrome in PD patients. dibromsalan 97-100 glucose-6-phosphate isomerase Homo sapiens 25-28 28297686-4 2017 He experienced the successful tremor relief after unipolar DBS in the globus pallidus internus(GPi)with Vercise<sup>TM</sup> but complained of dysarthria. dibromsalan 59-62 glucose-6-phosphate isomerase Homo sapiens 95-98 28297686-10 2017 A fine current steering of Vercise<sup>TM</sup> DBS is very useful in both, the early and late phases of GPi-DBS for dystonic syndrome. dibromsalan 60-63 glucose-6-phosphate isomerase Homo sapiens 117-120 23094951-2 2013 MATERIALS AND METHODS: We recorded local field potentials from the DBS lead in the GPi of four patients (seven hemispheres) with secondary dystonia and from one patient (two hemispheres) with primary DYT3+ dystonia. dibromsalan 67-70 glucose-6-phosphate isomerase Homo sapiens 83-86 26611690-1 2016 BACKGROUND: Dystonia has been treated well using deep brain stimulation at the globus pallidus internus (GPi DBS). dibromsalan 109-112 glucose-6-phosphate isomerase Homo sapiens 105-108 26611690-9 2016 CONCLUSIONS: The clinical outcome of phasic-type cervical dystonia is more favorable than that of tonic-type cervical dystonia following GPi DBS. dibromsalan 141-144 glucose-6-phosphate isomerase Homo sapiens 137-140 26002621-16 2015 The positive effects of GPi-DBS on the symptoms of spasmodic dysphonia merits further research as DBS is not commonly applied in this population. dibromsalan 28-31 glucose-6-phosphate isomerase Homo sapiens 24-27 23611688-8 2013 GPi was targeted in four patients with bilateral DBS procedure in every patient from this subgroup. dibromsalan 49-52 glucose-6-phosphate isomerase Homo sapiens 0-3 23611688-11 2013 Patients with GPi DBS had average DT improvement by approximately 50% but their dystonia symptoms were markedly improved. dibromsalan 18-21 glucose-6-phosphate isomerase Homo sapiens 14-17 26241157-10 2015 Multitarget DBS should be further explored in post-stroke dystonia and may offer improved outcome in other forms of secondary dystonia with limited response to GPi DBS. dibromsalan 12-15 glucose-6-phosphate isomerase Homo sapiens 160-163 25802776-6 2015 GPi DBS should be considered in dystonic PKAN patients provided fixed contractures and/or pyramidal symptoms are not present. dibromsalan 4-7 glucose-6-phosphate isomerase Homo sapiens 0-3